QMED — QMed Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for QMed, fiscal year end - November 30th, USD millions except per share, conversion factor applied.
R2003 November 30th | R2004 November 30th | R2005 November 30th | R2006 November 30th | 2007 November 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 12.7 | 15.3 | 22 | 8.14 | 5.25 |
| Cost of Revenue | |||||
| Gross Profit | 6.12 | 6.72 | 14.6 | 3.37 | 2.51 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 14.5 | 16.8 | 16.2 | 18.7 | 12.6 |
| Operating Profit | -1.88 | -1.45 | 5.72 | -10.6 | -7.39 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.17 | -1.9 | 5.29 | -9.53 | -4.82 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.19 | -1.69 | 5.01 | -9.49 | -4.85 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -2.15 | -1.74 | 3.89 | -14.2 | -11.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -2.15 | -1.74 | 3.89 | -14.2 | -11.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.14 | -0.114 | 0.271 | -0.565 | -0.286 |
| Dividends per Share |